Shandong Weigao Orthopaedic Device Co., Ltd (SHA:688161)
China · Delayed Price · Currency is CNY 29.54
+0.81 (2.82%)
At close: Mar 6, 2026
SHA:688161 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,539 | 1,451 | 1,282 | 2,057 | 2,152 |
Other Revenue | - | 2.21 | 1.33 | 0.93 | 1.58 |
| 1,539 | 1,453 | 1,284 | 2,058 | 2,154 | |
Revenue Growth (YoY) | 5.95% | 13.18% | -37.63% | -4.44% | 18.08% |
Cost of Revenue | - | 537.6 | 460.3 | 489.5 | 409.09 |
Gross Profit | 1,539 | 915.12 | 823.24 | 1,568 | 1,744 |
Selling, General & Admin | - | 573.21 | 621.81 | 786.46 | 827.36 |
Research & Development | - | 119.9 | 130.2 | 117.66 | 121.23 |
Other Operating Expenses | 1,217 | 13.73 | 14.21 | 28.89 | 31.26 |
Operating Expenses | 1,217 | 698.56 | 760.93 | 948.03 | 983.99 |
Operating Income | 322.14 | 216.56 | 62.31 | 620.45 | 760.46 |
Interest Expense | - | -1.04 | -0.95 | -0.61 | -0.61 |
Interest & Investment Income | - | 44.8 | 56.11 | 64.57 | 42.93 |
Currency Exchange Gain (Loss) | - | -1 | -1.24 | 2.18 | -0.51 |
Other Non Operating Income (Expenses) | -0.85 | -1.18 | 10.58 | 6.02 | -6.28 |
EBT Excluding Unusual Items | 321.29 | 258.14 | 126.82 | 692.6 | 795.99 |
Impairment of Goodwill | - | -0.24 | -0.17 | - | - |
Gain (Loss) on Sale of Investments | - | 0.32 | 0.13 | - | - |
Gain (Loss) on Sale of Assets | - | 6.35 | -0.02 | 0.23 | -0.11 |
Other Unusual Items | - | 6.36 | 4.86 | 13.38 | 14.05 |
Pretax Income | 321.29 | 270.94 | 131.62 | 706.21 | 809.93 |
Income Tax Expense | 54.65 | 42.66 | 18.53 | 105.85 | 118.59 |
Earnings From Continuing Operations | 266.64 | 228.29 | 113.09 | 600.36 | 691.33 |
Minority Interest in Earnings | - | -4.53 | -0.78 | 0.35 | -1.01 |
Net Income | 266.64 | 223.75 | 112.32 | 600.7 | 690.32 |
Net Income to Common | 266.64 | 223.75 | 112.32 | 600.7 | 690.32 |
Net Income Growth | 19.17% | 99.22% | -81.30% | -12.98% | 23.62% |
Shares Outstanding (Basic) | 398 | 400 | 401 | 400 | 379 |
Shares Outstanding (Diluted) | 398 | 400 | 401 | 400 | 379 |
Shares Change (YoY) | -0.40% | -0.39% | 0.16% | 5.58% | 5.96% |
EPS (Basic) | 0.67 | 0.56 | 0.28 | 1.50 | 1.82 |
EPS (Diluted) | 0.67 | 0.56 | 0.28 | 1.50 | 1.82 |
EPS Growth | 19.64% | 100.00% | -81.33% | -17.58% | 16.67% |
Free Cash Flow | - | 249.85 | 76.46 | 392.8 | 675.84 |
Free Cash Flow Per Share | - | 0.63 | 0.19 | 0.98 | 1.78 |
Dividend Per Share | - | 0.290 | 0.120 | 0.410 | 0.520 |
Dividend Growth | - | 140.70% | -70.62% | -21.15% | - |
Gross Margin | 100.00% | 62.99% | 64.14% | 76.22% | 81.00% |
Operating Margin | 20.93% | 14.91% | 4.86% | 30.15% | 35.31% |
Profit Margin | 17.32% | 15.40% | 8.75% | 29.19% | 32.05% |
Free Cash Flow Margin | - | 17.20% | 5.96% | 19.09% | 31.38% |
EBITDA | 375.48 | 269.9 | 120.22 | 677.35 | 811.94 |
EBITDA Margin | 24.39% | 18.58% | 9.37% | 32.91% | 37.70% |
D&A For EBITDA | 53.34 | 53.34 | 57.91 | 56.91 | 51.48 |
EBIT | 322.14 | 216.56 | 62.31 | 620.45 | 760.46 |
EBIT Margin | 20.93% | 14.91% | 4.86% | 30.15% | 35.31% |
Effective Tax Rate | 17.01% | 15.74% | 14.08% | 14.99% | 14.64% |
Revenue as Reported | - | - | - | 2,058 | 2,154 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.